The SEC Form 4 filing shows the shares were sold at a weighted‑average price of $37.71, yielding roughly $1.47 million in proceeds. After the transactions, Leach retained 823,886 shares, valued at about $32.24 million based on the Sept. 9 market close.
The sales were carried out under a Rule 10b5‑1 plan adopted on March 5, 2026, which lets insiders pre‑schedule sales to manage liquidity without attempting to time the market.
In addition to the outright sale, Leach exercised 15,142 stock options with a $3.99 strike price. The underlying shares were immediately sold at weighted‑average prices ranging from $36.57 to $38.33, effectively converting the options into cash.
At the time of the transaction, Ibotta’s stock had delivered a one‑year total return of 45%, while since 2024 the company’s shares have underperformed the S&P 500 by 59%. Recent financials show a swing from a near‑$100 million profit in 2025 to an $11 million loss over the last twelve months, and free cash flow has fallen from $105 million to $59 million.
Analysts note that insider sales often reflect personal financial planning and do not necessarily signal a change in a company’s outlook. Ibotta continues to grow its Performance Network platform and has authorized a $400 million share‑repurchase program to support the stock.
Investors will likely watch how Leach’s retained stake and the broader repurchase plan affect market perception as Ibotta expands its network with major retailers.